| created | [InstanceEdit:9690100] Orlic-Milacic, Marija, 2020-05-25 |
| dbId | 9690101 |
| displayName | In its GTP bound active form, plasma membrane associated RHO... |
| modified | [InstanceEdit:9714345] Orlic-Milacic, Marija, 2021-02-10 |
| schemaClass | Summation |
| text |
In its GTP bound active form, plasma membrane associated RHOA (or constitutively active RHOA mutant in the high throughput study by Bagci et al. 2020) binds to the following effectors: ANLN (Piekny and Glotzer 2008; Budnar et al. 2019; Bagci et al. 2020) CIT (Madaule et al. 1995; Bagci et al. 2020) and its neuron specific splicing isoform CIT 3 (Di Cunto et al. 1998) DAAM1 (Aspenstrom et al. 2006; Higashi et al. 2008) DIAPH1 (Otomo et al. 2005; Higashi et al. 2008; Lammers et al. 2008; Gao et al. 2009; Li and Sewer 2010; Bagci et al. 2020) DIAPH3 (Alberts et al. 1998; Watanabe et al. 2010; Staus et al. 2011; Chen et al. 2017; Bagci et al. 2020) IQGAP1 (Casteel et al. 2012) PKN1 (Maesaki et al. 1999; Hutchinson et al. 2011; Hutchinson et al. 2013) PKN2 (Hutchinson et al. 2013; Bagci et al. 2020) PKN3 (Hutchinson et al. 2013) PLD1 (Hammond et al. 1997; Yamazaki et al. 1999) RHPN1 (Watanabe et al. 1996; Peck et al. 2002) RHPN2 (Peck et al. 2002) ROCK1 (Ishizaki et al. 1996; Leung et al. 1996; Bagci et al. 2020) ROCK2 (Leung et al. 1996; Bagci et al. 2020) RTKN (Reid et al. 1996; Fu et al. 2000) SLK (Bagci et al. 2020: interaction and activation of SLK downstream of RHOA confirmed in detail) STK10 (Bagci et al. 2020: interaction corroborated by additional experimental methods) The following putative RHOA effectors are annotated as candidates either because of opposing findings reported by different studies or because their binding to RHOA was only shown in the context of constitutively active RHOA mutant in the high throughput screen by Bagci et al. 2020: AAAS (Bagci et al. 2020) ABCD3 (Bagci et al. 2020) ACBD5 (Bagci et al. 2020) ACTC1 (Bagci et al. 2020) ARHGAP1 (Bagci et al. 2020) BCR (Bagci et al. 2020) C1QBP (Bagci et al. 2020) CAV1 (Bagci et al. 2020) CAVIN1 (Bagci et al. 2020) DEPDC1B (Bagci et al. 2020) ERBIN (Bagci et al. 2020) FAF2 (Bagci et al. 2020) FLOT1 (Bagci et al. 2020) FLOT2 (Bagci et al. 2020) FMNL3 (Bagci et al. 2020: binding to RHOA; Vega et al. 2011: no binding to RHOA) HMOX2 (Bagci et al. 2020) IQGAP3 (Bagci et al. 2020) JUP (Bagci et al. 2020) MCAM (Bagci et al. 2020) MYO9B (Bagci et al. 2020) PCDH7 (Bagci et al. 2020) SCFD1 (Bagci et al. 2020) SNAP23 (Bagci et al. 2020) SOWAHC (Bagci et al. 2020) STBD1 (Bagci et al. 2020) STOM (Bagci et al. 2020) TFRC (Bagci et al. 2020) TJP2 (Bagci et al. 2020) TMPO (Bagci et al. 2020) VAMP3 (Bagci et al. 2020) VANGL1 (Bagci et al. 2020) RHOA does not bind the following effectors: CCDC187 (Bagci et al. 2020) CDC42BPA (Leung et al. 1998) CDC42BPB (Leung et al. 1998) CDC42EP1 (Joberty et al. 1999) CDC42EP2 (Joberty et al. 1999) CDC42EP3 (Joberty et al. 1999) CDC42EP4 (Joberty et al. 1999) CDC42EP5 (Joberty et al. 1999) FMNL2 (Kitzing et al. 2010) IQGAP2 (Brill et al. 1996) KIAA0355 (Bagci et al. 2020) PLD2 (Kodaki and Yamashita 1997) WAS (WASP) (Aspenstrom et al. 1996) |
| (summation) |
© 2026 Reactome